In his first public appearance as SEC chairman, Paul Atkins opened the latest crypto roundtable in the agency's Washington headquarters.

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission ...

Elevation Oncology, Inc. , an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

The new head of the U.S. Securities and Exchange Commission on Friday said that the agency has stifled innovation for the ...

A highly specific taxonomy is needed for the U.S. to move forward with crypto regulation, the company argued in a letter to ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation, have ...

The Trump administration has chosen to issue various executive orders and implement other actions under the president’s ...

PM CDT at the ASCO Annual MeetingMIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ...

Agenus Inc. , a leader in immuno-oncology, today announced three upcoming presentations at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 ? June 3 in Chicago ...

Whenever you jump into a conversation on Reddit and the subject of a financial advisor comes up, look out, as it can get the ...